Opinion

Video

Case 3: Persistently Active Central Retinal Vein Occlusion

Author(s):

Lisa J. Faia, MD ,David R. Lally, MD

In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), explaining her approach to switching this treatment-resistant patient to a newer agent.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
Related Content
(Image credit: AdobeStock/FourLeafLover) Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series
September 12th 2025

Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” series

3 Things You Should Know About the GA Pipeline
September 12th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

(Image credit: AdobeStock/racesy) Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
September 12th 2025

Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting

3 Things You Should Know About the GA Pipeline
September 12th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: Ophthalmology Times) From firsts to the future: A pioneer's perspective on ophthalmology
September 12th 2025

From firsts to the future: A pioneer's perspective on ophthalmology

(Image credit: AdobeStock/InkInvent) FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
September 12th 2025

FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy

© 2025 MJH Life Sciences

All rights reserved.